Article information
Full text is only aviable in PDF
REFERENCES
[1)]
J. Chastre, J.-L. Trouilet.
Nosocomial pneumonia: uidelines for initial management and empirical treatment, 101-117.
[2)]
M. Niederman, A. Fein.
Acute Infectious Pneumonia.
Intensive Care Medicine, 3, pp. 903-922
[3)]
S. Ewig, A. Torres, M. El-Ebiary.
Bacterial colonization patterns in mechanically ventilated patients with traumatic and medical head injury incidence, risk factors, and association with ventilator-associated pneumonia.
Am J Respir Crit Care Med, 159 (2001), pp. 188-198
[4)]
R.S. Edson, C.L. Terrell.
The aminoglycosides.
Mayo Clin Proc, 74 (1999), pp. 519-528
[5)]
A.D. Kashuba, A.N. Nafziger, G.L. Drusano, et al.
Optimizing aminoglycoside therapy for nosocomial pneumonia caused by Gram-negative bacteria.
Antimicrob Agents Chemother, 43 (1999), pp. 623-629
[6)]
EORTC International Antimicrobial Therapy Cooperative Group.
Ceftazedime combined with a short or long course of amikacin for empirical therapy of Gram-negative bacteremia in cancer patients with granulopenia.
N Engl J Med, 317 (1987), pp. 1692-1698
[7)]
P. Dore, R. Robert, G. Grollier, et al.
Incidence of anaerobes in ventilator-associated pneumonia with use of a protected specimen brush.
Am J Respir Crit Care Med, 153 (1996), pp. 1292-1298
[8)]
M. Kollef.
Antimicrobial Therapy of Ventilator- Associated Pneumonia.
Chest, 115 (1999), pp. 8-11
[9)]
J.-Y. Fagon, J. Chastre, Y. Domart, et al.
Nosocomial pneumonia in patients receiving continuous mechanical ventilation: prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques.
Am Rev Respir Dis, 139 (1989), pp. 877-884
[10)]
J. Cello, V. Asian, M. Ricer, et al.
Impact of previous ant microbial therapy on the etiology and outcome of ventilator-associated pneumonia.
Chest, 104 (1993), pp. 123-1235
[11)]
M. Ferrer, M. Ioanas, A. Torres.
Evaluation of Nonresponding Patients with Ventilator-associated Pneumonia.
2002 Yearbook of Intensive Care and Emergency Medicine, pp. 365-375
[12)]
D. Wyncoll, R. Bowry, L. Giles.
Antibiotics by Continuous Infusion: Time for Re-evaluation?.
2002 Yearbook of Intencive Care and Emergency Medicine, pp. 399-406
[13)]
P.J. Cole.
The role of Nebulized Antibiotics in Treating Serious Respiratory Infections.
Journal of Chemotherapy, 13 (2001), pp. 354-362
[14)]
J.-Y. Fagon.
Nosocomial Pneumonia: Duration of Antimicrobial Therapy,
Copyright © 2002. Sociedade Portuguesa de Pneumologia/SPP
Special content about COVID-19
- Issue 4—Impact of air pollution on COVID-19 mortality and morbidity: An epidemiological and mechanistic review
- Hyperoxemia in invasively ventilated COVID–19 patients–Insights from the PRoVENT–COVID study
- Association between respiratory distress time and invasive mechanical ventilation in COVID-19 patients: A multicentre regional cohort study
- Assisted mobilisation in critical patients with COVID-19
Open access
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publish in
Pulmonology
Pulmonology
- Home
- All contents
- Publish your article
- About the journal
- Metrics
- Open access
Article options